STALICLA signs Cooperative Research and Development Agreement (CRADA) with US National Institute on Drug Abuse (NIDA) to cover Phase 3 development of mavoglurant in cocaine use disorder
Globe Newswire8-03-2023, 18:00
Unipart secures three-year contract with Scania in China 11-06-2025, 22:25